• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

进化的优生学与“他者化”的强化:生殖领域基因编辑的伦理法律新视角

Evolved Eugenics and Reinforcement of "Othering": Renewed Ethico-Legal Perspectives of Genome Editing in Reproduction.

作者信息

Lau Pin Lean

机构信息

Brunel Law School, Brunel University London, Uxbridge UB8 3PH, UK.

出版信息

BioTech (Basel). 2023 Jul 11;12(3):51. doi: 10.3390/biotech12030051.

DOI:10.3390/biotech12030051
PMID:37489485
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10366906/
Abstract

This article extends an exploration into renewed ethico-legal perspectives of genome editing technologies, examined from an evolved conceptualization of eugenics in contemporary human reproduction. Whilst the ethico-legal conundrums presented by genome-editing technologies in various aspects of modern medicine have thus far inspired a comprehensive trove of academic scholarship-and notwithstanding the World Health Organization's (WHO) publication of guidelines on human genome editing in 2021-the legislative landscape for these technologies remain relatively unchanged. Accordingly, this paper presents the unresolved problematic questions that still require significant reflection. First, the paper highlights these questions, which primarily center around the tension between reproductive autonomy and the legal governance of reproductive/genome editing technologies by a democratic state. Secondly, the paper interrogates the evolved conceptualization of eugenics, exercised on the part of prospective parents as part of reproductive autonomy. By this, the paper predicates that it indirectly reinforces societal and systemic problems of discrimination and "othering", increasing reproductive inequalities in excluded communities. Thirdly, the paper attempts to offer narratives of intersectionality as a facilitating tool in a continuing dialogue to build belonging, foster a healthy and balanced exercise of reproductive autonomy, and increase reproductive equalities.

摘要

本文拓展了对基因编辑技术新的伦理法律视角的探讨,这一探讨是从当代人类生殖中优生学概念的演变来审视的。尽管基因编辑技术在现代医学各个方面所呈现的伦理法律难题,迄今为止激发了大量丰富的学术研究成果——而且尽管世界卫生组织(WHO)在2021年发布了人类基因编辑指南——但这些技术的立法状况仍相对未变。因此,本文提出了仍需深入思考的未解决的问题。首先,本文强调了这些问题,它们主要围绕生殖自主权与民主国家对生殖/基因编辑技术的法律治理之间的紧张关系。其次,本文审视了优生学概念的演变,这是准父母作为生殖自主权一部分所践行的。据此,本文断定这间接强化了社会和系统性的歧视及“他者化”问题,加剧了被排斥群体中的生殖不平等。第三,本文试图提供交叉性的叙述,作为一种促进工具,以便在持续对话中建立归属感,促进健康、平衡地行使生殖自主权,并增强生殖平等。

相似文献

1
Evolved Eugenics and Reinforcement of "Othering": Renewed Ethico-Legal Perspectives of Genome Editing in Reproduction.进化的优生学与“他者化”的强化:生殖领域基因编辑的伦理法律新视角
BioTech (Basel). 2023 Jul 11;12(3):51. doi: 10.3390/biotech12030051.
2
Genome Editing: Learning from Its Past and Envisioning Its Future.基因组编辑:从过去中学习并展望未来。
Eur J Health Law. 2022 Apr 8;29(3-5):341-358. doi: 10.1163/15718093-bja10081.
3
Guerrilla eugenics: gene drives in heritable human genome editing.游击优生学:可遗传人类基因组编辑中的基因驱动
J Med Ethics. 2023 Jul 4. doi: 10.1136/jme-2023-109061.
4
Genome editing and assisted reproduction: curing embryos, society or prospective parents?基因组编辑与辅助生殖:治愈胚胎、社会还是准父母?
Med Health Care Philos. 2018 Jun;21(2):215-225. doi: 10.1007/s11019-017-9793-y.
5
Human genome editing: how to prevent rogue actors.人类基因组编辑:如何防范恶意行为者。
BMC Med Ethics. 2020 Oct 6;21(1):95. doi: 10.1186/s12910-020-00527-w.
6
From Public Eugenics to Private Eugenics: What Does the Future Hold?从公共优生学到私人优生学:未来会怎样?
JBRA Assist Reprod. 2022 Nov 9;26(4):666-674. doi: 10.5935/1518-0557.20220032.
7
Bioethical issues in genome editing by CRISPR-Cas9 technology.CRISPR-Cas9技术在基因组编辑中的生物伦理问题。
Turk J Biol. 2020 Apr 2;44(2):110-120. doi: 10.3906/biy-1912-52. eCollection 2020.
8
Effect of the Human Genome Initiative on women's rights and reproductive decisions.人类基因组计划对妇女权利和生殖决策的影响。
Fetal Diagn Ther. 1993 Apr;8(Suppl. 1):148-59. doi: 10.1159/000263882.
9
Moving Beyond 'Therapy' and 'Enhancement' in the Ethics of Gene Editing.超越基因编辑伦理中的“治疗”与“增强”
Camb Q Healthc Ethics. 2019 Oct;28(4):695-707. doi: 10.1017/S0963180119000641.
10
Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.通过 CRISPR/Cas9 技术对人类生殖细胞和多能干细胞进行基因组编辑。
Hum Reprod Update. 2016 Jun;22(4):411-9. doi: 10.1093/humupd/dmw005. Epub 2016 Feb 29.

本文引用的文献

1
Addressing Cognitive Vulnerabilities through Genome and Epigenome Editing: Techno-Legal Adaptations for Persons with Intellectual Disabilities.通过基因组和表观基因组编辑解决认知脆弱性:智力残疾人士的技术法律适应。
Eur J Health Law. 2022 Apr 8;29(3-5):409-434. doi: 10.1163/15718093-bja10085.
2
Handle with Care: The WHO Report on Human Genome Editing.谨慎处理:世卫组织人类基因组编辑报告
Hastings Cent Rep. 2022 Mar;52(2):10-14. doi: 10.1002/hast.1350.
3
'Doing' or 'using' intersectionality? Opportunities and challenges in incorporating intersectionality into knowledge translation theory and practice.将交叉性纳入知识转化理论和实践之中:机会与挑战。
Int J Equity Health. 2021 Aug 21;20(1):187. doi: 10.1186/s12939-021-01509-z.
4
The social paradoxes of commercial surrogacy in developing countries: India before the new law of 2018.发展中国家商业代孕的社会悖论:2018年新法律出台前的印度
BMC Womens Health. 2020 Oct 15;20(1):234. doi: 10.1186/s12905-020-01087-2.
5
Science and Bioethics of CRISPR-Cas9 Gene Editing: An Analysis Towards Separating Facts and Fiction.CRISPR-Cas9基因编辑的科学与生物伦理学:区分事实与虚构的分析
Yale J Biol Med. 2017 Dec 19;90(4):625-634. eCollection 2017 Dec.
6
Public views on gene editing and its uses.公众对基因编辑及其应用的看法。
Nat Biotechnol. 2017 Nov 9;35(11):1021-1023. doi: 10.1038/nbt.3958.
7
Preimplantation genetic diagnosis and screening: Current status and future challenges.胚胎植入前遗传学诊断与筛查:现状与未来挑战。
J Formos Med Assoc. 2018 Feb;117(2):94-100. doi: 10.1016/j.jfma.2017.08.006. Epub 2017 Sep 6.
8
Human Germline Genome Editing.人类种系基因组编辑
Am J Hum Genet. 2017 Aug 3;101(2):167-176. doi: 10.1016/j.ajhg.2017.06.012.
9
Development and applications of CRISPR-Cas9 for genome engineering.用于基因组工程的CRISPR-Cas9技术的开发与应用。
Cell. 2014 Jun 5;157(6):1262-1278. doi: 10.1016/j.cell.2014.05.010.
10
AUTONOMY, LIBERTY, AND MEDICAL DECISION-MAKING.自主性、自由与医疗决策
Camb Law J. 2011 Nov;70(3):523-547. doi: 10.1017/S0008197311000845.